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Abstract 
 
Low socioeconomic status has been reported to be associated with head and neck cancer risk. 
However, previous studies have been too small to examine the associations by cancer subsite, 
age, sex, global region, and calendar time, and to explain the association in terms of 
behavioural risk factors. Individual participant data of 23,964 cases with head and neck cancer 
and 31,954 controls from 31 studies in 27 countries pooled with random effects models. 
Overall, low education was associated with an increased risk of head and neck cancer (OR = 
2·50; 95%CI 2·02– 3·09). Overall one-third of the increased risk was not explained by 
differences in the distribution of cigarette smoking and alcohol behaviours; and it remained 
elevated among never users of tobacco and non-drinkers (OR = 1·61; 95%CI 1·13 – 2·31). 
More of the estimated education effect was not explained by cigarette smoking and alcohol 
behaviours: in women than in men, in older than younger groups, in the oropharynx than in 
other sites, in South/Central America than in Europe/North America, and was strongest in 
countries with greater income inequality. Similar findings were observed for the estimated effect 
of low vs high household income. The lowest levels of income and educational attainment were 
associated with more than 2-fold increased risk of head and neck cancer, which is not entirely 
explained by differences in the distributions of behavioural risk factors for these cancers, and 
which varies across cancer sites, sexes, countries, and country income inequality levels. 
 
Key words: head and neck cancer, socioeconomic inequalities, epidemiology, 
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Introduction 
One hundred years ago, Charles Singer (1911), a London clinician, in a series of over 500 oral 
and pharyngeal cancer cases identified a preponderance of the disease among men and 
among low socioeconomic groups; in addition he hypothesised an association with alcohol and 
an infection (syphilis).1  
 
Today, head and neck cancer – comprising tumours of the mucosal lining of the oral cavity, 
pharynx, and larynx – is amongst the most common in the world, with an estimated annual 
burden of over 550,000 new cases and 300,000 deaths,2 and with wide variations in trends 
reported across the world by sex, age, and subsite.3 Increasing incidence of oral and/or 
oropharyngeal subsites has been observed in Denmark3, Netherlands4, Sweden5, the UK6-8, 
USA,9,10 parts of South/Central America3, and Japan3 – these increases being  mainly among 
men3, and sometimes among lower socioeconomic groups.3,8 Moreover, head and neck cancer 
has generally poor survival and impacts heavily on quality of life – such as: eating, speech, and 
physical appearance.11  
 
While smoking and alcohol behaviours have long been recognised as the major risk factors for 
head and neck cancer15, and more recently the role of genetic variants16 and human 
papillomavirus (HPV) infection17 have been identified, the burden and aetiology of head and 
neck cancer associated with socioeconomic factors are yet to be fully understood. Head and 
neck cancer risk has been strongly associated with lower socioeconomic status (SES) 
especially among men.18 The relative contributions of alcohol and tobacco consumption to the 
association of SES and head and neck cancer has varied considerably, with estimates of the 
unexplained or “direct” effect of low SES ranging from 10-50%.9-21 These estimates have been 
from studies combining all head and neck sites, usually limited to men, and with small sample 
sizes leading to imprecise estimates of the true burden of exposure unable to explain the 
association in terms of behavioural risk factors. In addition, while country income inequality has 
consistently been associated with numerous negative health outcomes22-25 to our knowledge no 
one has tested the hypothesis that the greater the country’s income inequality the greater the 
head and neck cancer risks associated with low relative educational attainment. 
 
We aim to assess the risk for head and neck cancer associated with low educational attainment 
and household income by age, sex, head and neck cancer subsite, and geographic location and 
to stratify the geographical location by the macroeconomic measure of income inequality.  
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Material and Methods 
The INternational Head And Neck Cancer (INHANCE) consortium is a global data pooling 
initiative for epidemiology studies of head and neck cancer. Study inclusion and methodological 
details including individual study design, control sources, participation proportions, and case 
definition have been previously described26,27 (Supplementary Table 1).  All studies frequency 
matched controls to cases minimally on age and sex, and additional factors in some studies 
(Table 1).  
 
At the time of this investigation, 35 studies (25,910 cases and 37,111 controls) were in the 
INHANCE pooled database (version 1.5). Data from 31 studies were included in the analysis 
because the France (1987–1992), Rome, Japan (1988–2000), and Japan (2001–2005) studies 
did not collect SES data. Case subjects had histologically confirmed diagnoses of cancers of 
the oral cavity, oropharynx, hypopharynx, oral cavity, oropharynx not otherwise specified, and 
larynx (ICD codes – see Supplementary Methods). We excluded lymphomas, sarcomas, and 
cancers of the nasopharynx and salivary glands.  
 
Education data were standardised using the International Standard Classification of Education 
(ISCED 97)28; and grouped into 3 strata: (i) low education level, which included no education, or 
completed the first stage of basic education, or at most primary education (ISCED 0–1); (ii) 
intermediate education level, which included lower secondary or second stage of basic 
education or completed upper secondary education (ISCED 2–4); and (iii) high education level, 
which comprised further education including vocational education and higher education 
including university degree (ISCED 5–6). Household income data were standardised as far as 
possible (given the original study questionnaire categorization) by grouping comparable levels 
based on the strata used in the original study questionnaires (Supplementary Table 2), with 
category 1 being the lowest and category 5 the highest income levels. 
 
We estimated study-specific odds ratios (OR) and 95% confidence intervals (CI) for the 
association of education and income for head and neck cancer, using unconditional logistic 
regression. For details on covariate inclusion and modelling strategy see Supplementary 
Methods. We then estimated the summary effect estimates using a meta-analysis approach: by 
pooling study-specific risk estimates with random effects models.29 For additional details on 
meta-analytic approaches and evaluation of heterogeneity see Supplementary Methods. We 
conducted a detailed series of subgroup analyses by smoking status; drinking status; cancer 
subsite; geographic region, age-group, country income inequality, control type and year of study 
conduct (Supplementary Methods). We also conducted a sensitivity analysis using a complete 
observation only dataset where no missing data existed across any variable in all studies in 
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order to determine the potential biased effects of sample size reduction resulting from including 
additional covariates.  
 
We estimated the proportion of the socioeconomic effect which remained after adjustment for 
behavioural risk factors by calculating the percentage change in OR as (OR1 – OR2) / (OR1 – 
1), where OR1 is the minimally adjusted model and OR2 is the model adjusted for behavioural 
risk factors referred to as attributable fraction for covariates.30 We then calculated the 
attributable fraction remaining/not explained by covariates by subtracting this from 100%. 
Statistical analyses were conducted using SAS v 9.2, and STATA v 10. 
 
Results  
The characteristics of included studies are presented in Table 1. There were 31 individual case-
control studies that included 23,964 head and neck cancer subjects and 31,954 control 
subjects. The characteristics of the study subjects are detailed in Table 2. The distribution of 
selected behavioural factors by educational attainment in study subjects generally shows that 
smoking, alcohol consumption, and diets low in fruit and vegetables are greater in those with 
lower education (Supplementary Table 3).  
 
Low relative to high educational attainment was associated with an increased risk of head and 
neck cancer (OR 2·50; 95%CI 2·02–3·09), with those in the intermediate level of educational 
attainment having an intermediate increased risk (OR 1·80; 95%CI 1·57–2·07) (Table 3). These 
associations were increasingly attenuated when models sequentially adjusted for lifestyle 
behaviours (Table 3); such that the proportion of the increased risk estimate associated with low 
educational attainment not explained by smoking alone was 58%; by smoking and alcohol 
combined was 31%; by smoking, alcohol, and diet was 29%, and by smoking, alcohol, diet, and 
other tobacco use was 23% (% computed from Table 3). The model adjusting for smoking and 
alcohol (Table 3 model 3) was adjusted further by including the cross-product terms involving 
alcohol and smoking to account for interaction on a multiplicative scale, however no further 
attenuation was observed (data not shown). Among those who never smoked, never used other 
tobacco, and never drank alcohol lower educational attainment remained associated with more 
than 50% increased risk (OR 1·61; 95%CI 1·13–2·31). Low relative to high household income 
was associated with a similar increased risk of head and neck cancer (OR 2·44; 95%CI 1·62–
3·67), and 39% of this risk was not explained when adjusting for smoking and alcohol (Table 3).  
 
Using our complete observation only dataset analysis, we observed very similar effects where 
low relative to high educational attainment was associated with an increased risk of head and 
neck cancer (OR 2·12; 95%CI 1·59–2·84), with those in the intermediate level of educational 
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attainment conferring an intermediate increased risk (OR 1·69; 95%CI 1·35–2·11) 
(Supplementary Table 4).. 
 
Figure 1 shows a forest plot of the study-specific risk estimates for low relative to high 
educational attainment (OR 1·86; 95%CI 1·54–2·25) and low relative to high household income 
(OR 1·82; 95%CI 1·57–2·11) in the models adjusting for age, sex, centre, smoking and alcohol 
behaviours. These results vary slightly from Table 3 due to using the data from the lowest and 
highest strata available (rather than limited to the absolute low and high categories used 
throughout). Studies that contributed to the heterogeneity of the overall pooled estimates were 
investigated using Galbraith radial plots (Supplementary Figures 1&2). Studies were removed in 
an iterative process until no further significant heterogeneity was observed. The examination of 
heterogeneity observed in the overall analysis of both education and income investigated no 
single factor was identified as the main cause of heterogeneity (results not shown). 
 
After adjustment for smoking and alcohol behaviours the risk associated with low education was 
greatest among those from higher income inequality countries OR 1·65 (95%CI 1·27–2·15), 
although there was not a clear pattern across the other levels of country income inequality 
(Table 4). There was a tendency for more of the effect associated with low education to be left 
unexplained by smoking and alcohol in middle- and higher-income inequality countries.  
 
Significant variation was observed in the risks associated with low relative to high education for 
the head and neck cancer subsites (p<0·05). The association was stronger for hypopharyngeal 
and laryngeal cancers than for oral cavity and oropharyngeal cancer. After adjustment for 
smoking and alcohol behaviours there were no significant differences, however, there was a 
tendency for more (around two thirds) of the risk associated with low education to remain 
unexplained by smoking and alcohol for oropharyngeal cancer compared to ( around one-third 
for) all other head and neck cancer sites (Table 4). 
 
The risk of head and neck cancer tended to be more strongly associated with lower educational 
attainment in North American studies and South / Central American studies with European 
studies. There was full attenuation of this risk association by adjustment for smoking and 
alcohol behaviours in European studies. By contrast, in the North American and South / Central 
American studies adjustment for smoking and alcohol left substantial socioeconomic risk 
unexplained by smoking and alcohol (Table 4).  
 
The risk associated with low relative to high educational attainment was lower for oral cavity in 
studies from Europe compared with those in North America and South / Central America, but 
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stronger for larynx cancer in North America compared to other regions (Supplementary Table 
5). The proportion of the risk left unexplained by smoking and alcohol behaviours by subsite and 
region was highly variable. 
 
The risk associated with lower educational attainment varied across global regions by sex and 
age subgroups (SupplementaryTable 6). We observed that it was only in the European studies 
where the elevated risk associated with lower educational attainment was found only among 
men and not in women. However, after adjustment for smoking and alcohol behaviours these 
differences do not remain significant as the elevated risk associations among women in both 
North and South/Central America  were attenuated. 
 
Discussion 
Our results from this large pooled analysis indicate that low socioeconomic status is a strong 
risk factor for head and neck cancer. We found that variation in the influence of socioeconomic 
status on the risk of head and neck cancer exists across the world, and that there is increased 
risk associated with both lower income levels and lower educational attainment with the 
strongest effect remaining among those from higher income inequality countries. We also 
showed that these findings are not confined to men, nor to older people, and they are not 
entirely explained by the traditional recognised lifestyle behavioural risk factors of smoking and 
alcohol, nor by diet or other tobacco use, although residual confounding could not be ruled out. 
 
The lowest levels of income and educational attainment are associated with a more than 2-fold 
increased risk of head and neck cancer, which remain elevated, although strongly attenuated 
after adjusting for smoking, other tobacco, alcohol, and diet risk factors. Adjustment for these 
behaviours reduced the increased risk associated with low educational attainment by around 
two-thirds, leaving a potentially unexplained risk, suggesting that low socioeconomic status 
confers risk that operates through pathways other than through these risk behaviours. This 
finding was further supported by the strong association with low educational attainment 
remaining in the analysis restricted to those who were never smokers, never tobacco users, and 
never drank alcohol, and by no studies showing the converse significant association of 
increased risk associated with higher educational attainment.  
 
Differences in the smoking epidemic by region, sex, and socioeconomic status may help explain 
the global differences we observed. North34 and South35 American smoking prevalence declined 
in the late 20th Century, but those with lower educational attainment, regardless of gender or 
ethnicity, had a higher prevalence of smoking over time and smoked longer.36,37 Prevalence 
among men remains greater than among women, but there has also been a more rapid and 
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greater decline in smoking prevalence for men than women irrespective of educational 
attainment.34,38 Our findings of a sustained effect associated with low education after adjusting 
for smoking and alcohol in North and South/Central America compared with Europe is 
consistent with earlier INHANCE analyses, which found the risk of head and neck cancer 
associated with smoking and alcohol was lower in North America.26,39 These differences were 
considered to be potentially due to variation in the tobacco carcinogen content of cigarettes 
(which have also changed over time)40 or could be due to other aspects of smoking behaviour 
such as the depth of inhalation, or interaction with alcohol. Alcohol consumption on its own has 
been shown to exert a weak risk association for head and neck cancer, however, in combination 
with smoking the risk is synergistically elevated39,41, although we did not observe magnified 
attenuation when we included adjustment for the interaction between cigarette smoking and 
alcohol. Hashibe et al (2009) reported a significant lower population attributable risk associated 
with tobacco and alcohol in North America relative to Europe or South / Central America, which 
was perhaps due to the lower proportion of cases who both smoked and drank alcohol in North 
America.39 These geographical differences suggest that other risk factors varying across 
populations may be more important in relation to explaining the socioeconomic associations 
with head and neck cancer risk. The role of sexual history and HPV are beginning to emerge as 
a potentially more important risk factor in North America17 compared to Europe42-44 or South 
America43 – particularly for oropharyngeal cancer. However, this is unlikely to explain these 
differences as sexual history and HPV do not seem be associated with low educational 
attainment.17 
 
Our findings that the risk associated with lower educational attainment was stronger for 
hypopharyngeal and laryngeal cancers than for oral cavity and oropharyngeal cancers and that 
adjustment by smoking and alcohol attenuated substantially less for oropharyngeal cancer is 
consistent with the evidence related to the risk associated with smoking which shows a similar 
pattern.45 Here, oropharyngeal cancer is the site least associated with socioeconomic 
differences, and the site for which socioeconomic differences are least explained by smoking 
and alcohol behaviours, which is also consistent with earlier findings that oropharyngeal cancer 
is strongly associated with HPV and risk factors for HPV-positive oropharyngeal cancers seem 
to differ from those of other head and neck cancers.17 
 
The causal mechanisms between low educational attainment or income and disease are via 
behavioural lifestyle factors46 and / or through psychosocial, material and life-course 
pathways.47 We have observed both an attenuation of the risk associated with low education in 
relation to head and neck cancer by behavioural factors, and also an as yet unexplained “direct” 
risk. Causal inference of low educational attainment is considered problematic on two counts – 
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firstly by the potential for reverse causation (i.e. low educational attainment itself is caused by 
underlying childhood health that could also be involved in the aetiology of the disease – 
although in terms of head and neck cancer this seem unlikely), and secondly by unobserved 
third variables such as IQ or time preference (whether one places emphasis on their present or 
future wellbeing), rather than educational attainment per se.24 
 
Our findings should be interpreted in light of several limitations inherent in pooled individual 
participant data analyses. Our first major concern was the heterogeneity across studies 
especially given the high number of studies from across the world. Much work has been done 
by INHANCE to ensure standardisation of case-definition and smoking and alcohol variables 
within the dataset. Here we endeavoured to standardise education levels using the UNESCO 
ISCED, which is a recognised instrument for cross-country education analysis48,49; and to 
standardise household income categories into US dollars in absolute terms as reported. 
Changes in the education systems (albeit unlikely in the relatively short time-frame covered by 
included studies) and in the absolute value of income over time are nevertheless potential 
limitations of the data. Heterogeneity was detected in the vast majority of associations and was 
mitigated as far as possible with random-effects logistic regression models. There were also 
limitations in the interpretation of our mediation analyses; we assumed no interaction between 
SES and behavioural factors in the risk of developing head and neck cancer and we assumed 
there were no unmeasured confounders of the association between behaviours and cancer risk. 
Therefore, we computed the proportion of the SES effect not attributable to behavioural factors.  
 
Our approach, adjusting for several metrics of smoking, tobacco, and alcohol behaviour 
variables and also including analysis in never smokers, other tobacco users, or alcohol drinkers, 
attempted to limit the effects of potential residual confounding associated with these behaviours. 
However, we have to acknowledge the risk of residual confounding remains. Inconsistent 
results have been reported in the literature with regard to the relationship of between SES and 
reported smoking behaviours – with higher rates of under-reporting of smoking among men and 
women with lower education attainment in the United States50, but no such differences reported 
in European studies.51 This could explain some of the differences in attenuation of the head and 
neck risk associated with education by behaviours we observed between regions. Furthermore, 
we were also unable to adjust for other potential risk factors, which could explain the 
association with low educational attainment such as HPV infection or working conditions and/or 
occupational exposures – the latter previously identified as a potential explanatory factor for 
socioeconomic inequalities in head and neck21 and for lung cancer.52   
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We did not identify any substantial differences in results between sources of control subjects 
which reassures against the risk of selection bias, particularly associated with hospital source 
controls. Moreover, there was some variability in control matching factors across studies (Table 
1). A number of studies matched on neighbourhood, residence, and ethnicity – all which could 
potentially overmatch on socioeconomic factors and could have led to an underestimate of the 
SES effect observed. A final limitation of our study was the lack of data from Asia – particularly 
South East Asia where incidence of head and neck cancer is high.2 Moreover, we investigated 
potential publication bias via visual examination of a Funnel plot, which indicated no significant 
publication bias (Supplementary Figure 3).  
In conclusion we found that a third of the risk for head and neck cancer associated with low 
education was not explained by the major behavioural risk factors, which chimes with previous 
estimates that 70% of head and neck cancers are “avoidable” by lifestyle changes – particularly 
smoking and alcohol behaviours.39,41 Therefore, lifestyle factors need to be considered in their 
socioeconomic context – both with regard to understanding the disease aetiology, but also in 
relation to prevention.  
 
The consistent risk associated with low education for head and neck cancer is a cause for 
concern. The differences in head and neck cancer subsite, age, sex and region – provide some 
potential direction for future aetiological research to better understand the causes of this 
disease. The association of low education with head and neck cancer risk even after thorough 
adjustment for known behavioural risk factors indicates the potential role of yet unidentified risk 
factors and pathways that are associated with socioeconomic status. 
 
This knowledge could also begin to more explicitly underpin the development of more tailored 
preventive approaches for head and neck cancer, including risk profiling with SES as developed 
for other conditions such as cardiovascular disease53, but thus far largely ignored in relation to 
head and neck cancer.54 
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Results 
 
Table 1        Characteristics of individual studies of the INHANCE consortium pooled analysis 
Sources of Participation rate (%) 
Location INHANCE ID Region Period controls Cases / Controls E I Oral cavity Oropharynx
Oc/Op         
NOS Hypopharynx Larynx
Mixed/   
Missing
Controls 
(n)
Cases       
(n)
France * Paris (1989-1991) Europe 1989-1991 H 80 / 86 X . . . 206 322 0 305 528
France * Paris (2001-2007) Europe 2001-2007 P 82.5 / 80.6 X 468 692 155 413 509 0 3555 2237
Italy (Aviano) Aviano Europe 1987-1992 H >95 / 95 X 85 148 33 70 146 0 855 482
Italy multicenter * Italy multicenter Europe 1990-2005 H >95 / >95 X 209 359 90 143 460 0 2716 1261
Italy (Milan) Milan (1984-1989) Europe 1984-1989 H 95 / 95 X 48 34 65 27 242 0 1531 416
Italy (Milan) Milan (2006-2009) Europe 2006-2009 H >95 / >95 X 85 21 18 17 229 0 755 370
Switzerland (Lausanne) Switzerland Europe 1996-1999 H >95 / >95 X 138 151 7 96 124 0 883 516
Germany (Heidelberg) Germany-Heidelberg Europe 1998-2000 P 96 / 62 X . . . . 246 6 769 252
Central Europe * Central Europe Europe 1998-2003 H 96 / 97 X 196 98 32 52 384 0 907 762
Western Europe * Western Europe Europe 2000-2005 H & P 82 / 68 X 482 439 106 154 539 8 1993 1728
Germany (Saarland) Germany-Saarland Europe 2001-2003 P 94 / not known X 15 30 9 13 27 0 94 94
US Multicentre * USmulticenter North America 1983-1984 P 75 / 76 X 386 389 218 121 . 0 1268 1114
USA (New York) * New York Multicenter North America 1981-1990 H 91 / 97 X 536 502 64 62 286 0 1610 1450
USA (Seattle) Seattle (1985-1995) North America 1985-1995 P 54&63 / 63&61† X 224 174 14 . . 0 615 412
USA (Iowa) Iowa North America 1993-2006 H 87 / 92 X X 254 150 38 11 95 8 760 556
USA (North Carolina) Norh Carolina (1994-
1997)
North America 1994-1997 H 88 / 86 X 42 44 25 17 52 0 202 180
USA (Baltimore) Baltimore North America 2000-2005 H 100 / 100 X X 46 108 . 6 49 0 200 209
USA (Tampa) Tampa North America 1994-2003 H 98 / 90 X 22 57 65 1 63 5 899 213
USA (Boston) Boston North America 1999-2003 P 89 / 49 X X 139 247 43 44 111 1 659 585
USA (Houston) Houston North America 2001-2006 H 95 / >80 X X 238 387 10 38 154 2 866 829
USA (Buffalo) Buffalo North America 1982-1998 H 50 / 50 X X 218 141 36 46 191 0 1254 632
USA (Baltimore) HOTSPOT North America 2009-2012 H >85 / >80 X X . 71 . . . 0 71 71
USA (North Carolina) North Carolina (2002-
2006)
North America 2002-2006 P 82 / 61 X X 194 372 251 70 481 0 1396 1368
USA (Los Angeles) Los Angeles North America 1999-2004 P 49 / 68 X X 53 156 112 17 90 0 1040 428
USA (Seattle) Seattle-Leo North America 1983-1987 P 81 / 75 X 183 151 47 61 209 6 547 657
USA (New York) MSKCC North America 1992-1994 H >95 / >95 X X 72 13 2 11 42 25 171 165
Puerto Rico Puerto Rico South/Central America 1992-1995 P 71 / 83 X X 94 143 57 57 . 0 521 351
Latin America * Latin America South/Central America 2000-2003 H 95 / 86 X 459 395 240 180 860 66 1706 2200
Brazil (Sao Paulo) SaoPaulo South/Central America 2002-2007 H >95 / >95 X 769 326 64 180 574 9 1670 1922
International * Intl Multicenter Global 1992-1997 H 89 / 87 X 828 347 135 . . 262 1732 1572
China (Beijing) Beijing Asia 1988-1989 H 100 / 100 X 404 . . . . 0 404 404
TOTAL Total 6887 6145 1936 2113 6485 398 31954 23964
E - education data; I - household income data; X - data present; H - hospital-based controls; P - population-based controls; OC/OP NOS - oral cavity and / or oropharynx not specified
* - multicenter study
† - Two response rates are reported because data were collected in two population-based case-control studies, the first from 1985 to 1989 among men and the second from 1990 to 1995 
‡ - All studies frequency matched controls to cases minimally on age and sex. Additional frequency matching factors included: center/city/region (France 2001-2007, Central Europe, Latin America, Sao Paulo, 
Western Europe, International Multicenter), Hospital (France 1989-1991, New York Multicenter, Sao Paulo), Neighbourhood (Los Angeles, Boston), ethnicity (Central Europe, Tampa, Houston, Latin America, 
US Multicenter, Western Europe, North Carolina (2002-2006), HOTSPOT), Residence (Germany Saarland), HPV status (Baltimore)
Cancer (n)
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Table 2a           Distribution of INHANCE Consortium head and neck cancer cases and control-subjects by selected  
                           demographic, behavioural, study design characteristics, and tumour subsite by sex 
 
Controls Cases Controls Cases Controls Cases
Variable (n=9210) (n=5070) (n=22744) (n=18894) (n=31954) (n=23964)
n % n % n % n % n % n %
Age (years) < 50 2265 24.59 964 19.01 4939 21.72 3566 18.87 7204 22.54 4530 18.9
50 + 6945 75.41 4106 80.99 17805 78.28 15328 81.13 24750 77.46 19434 81.1
Global region Europe 4072 44.21 1601 31.58 12242 53.83 8354 44.22 16314 51.05 9955 41.54
North America 3479 37.77 2295 45.27 6927 30.46 6011 31.81 10406 32.57 8306 34.66
South/Central America 1142 12.4 706 13.93 2955 12.99 3911 20.7 4097 12.82 4617 19.27
Other 517 5.61 468 9.23 620 2.73 618 3.27 1137 3.56 1086 4.53
Country income inequality Lower <6 758 8.23 518 10.22 2155 9.48 2087 11.05 2913 9.12 2605 10.87
(ratio income share Mid 6-8 2031 22.05 643 12.68 5632 24.76 3323 17.59 7663 23.98 3966 16.55
richest 20% : poorest 20%) Higher >8 4532 49.21 2955 58.28 9559 42.03 9718 51.43 14091 44.1 12673 52.88
missing 1889 20.51 954 18.82 5398 23.73 3766 19.93 7287 22.8 4720 19.7
Education (ISCED) Low (0 - 1) 3183 34.56 1718 33.89 7118 31.3 7517 39.79 10301 32.24 9235 38.54
Intermediate (2 - 4) 2899 31.48 1862 36.73 7340 32.27 6508 34.44 10239 32.04 8370 34.93
High (5 - 6) 2993 32.5 1349 26.61 7934 34.88 4201 22.23 10927 34.2 5550 23.16
missing 135 1.47 141 2.78 352 1.55 668 3.54 487 1.52 809 3.38
Annual household income 1 (<$15,000) 557 6.05 443 8.74 1011 4.45 1113 5.89 1568 4.91 1556 6.49
(US $) 2 ($15,000 - <$30,000) 252 2.74 161 3.18 577 2.54 429 2.27 829 2.59 590 2.46
3 ($30,000 - $45,000) 237 2.57 133 2.62 616 2.71 388 2.05 853 2.67 521 2.17
4 ($45,000 - <$60,000) 193 2.1 111 2.19 425 1.87 325 1.72 618 1.93 436 1.82
5 ($60,000 +) 481 5.22 247 4.87 1496 6.58 1047 5.54 1977 6.19 1294 5.4
missing 7490 81.32 3975 78.4 18619 81.86 15592 82.52 26109 81.71 19567 81.65
Study design Hospital-based 6295 68.35 3311 65.31 14800 65.07 12847 68 21095 66.02 16158 67.43
Population-based 2915 31.62 1759 34.69 7944 34.92 6047 31.99 10859 33.97 7806 32.56
Time of study recruitment Pre-2000 studies 4712 51.16 2466 48.64 11066 48.65 7874 41.67 15778 49.38 10340 43.15
2000-onward studies 4498 48.81 2604 51.36 11678 51.34 11020 58.31 16176 50.61 13624 56.84
Subsite of tumour Oral cavity 2122 41.85 4765 25.22 6887 28.74
Oropharynx 1237 24.4 4908 25.98 6145 25.64
OC/OP NOS 240 4.73 1873 9.91 2113 8.82
Hypophayrnx 535 10.55 1401 7.42 1936 8.08
Larynx 843 16.63 5642 29.86 6485 27.06
Mixed 75 1.48 256 1.35 331 1.38
Missing 18 0.36 49 0.26 67 0.28
AllSex
Women Men Overall
 
 
 
 
 21 
Table 2b            Distribution of INHANCE Consortium head and neck cancer cases and control-subjects by   
                           Smoking, alcohol, and dietary variables by sex 
 
Controls Cases Controls Cases Controls Cases
Variable (n=9210) (n=5070) (n=22744) (n=18894) (n=31954) (n=23964)
n % n % n % n % n % n %
Smoking (pack-years) 0 <=10 1223 13.28 410 8.09 3162 13.9 1044 5.53 4385 13.72 1454 6.07
10-<=20 758 8.23 435 8.58 2923 12.85 1453 7.69 3681 11.52 1888 7.88
20-<=30 508 5.52 496 9.78 2562 11.26 2271 12.02 3070 9.61 2767 11.55
30-<=40 386 4.19 534 10.53 2205 9.69 2867 15.17 2591 8.11 3401 14.19
40-<=50 252 2.74 488 9.63 1551 6.82 2534 13.41 1803 5.64 3022 12.61
> 50 385 4.18 1008 19.88 2882 12.67 6086 32.21 3267 10.22 7094 29.6
missing 60 0.65 57 1.12 533 2.34 822 4.35 593 1.86 879 3.67
Other Tobacco status Never 4669 50.69 1058 20.87 5222 22.96 953 5.04 9891 30.95 2011 8.39
Ever 1544 16.76 685 13.51 7849 34.51 4409 23.34 9393 29.4 5094 21.26
Current 1589 17.25 2491 49.13 6650 29.24 10787 57.09 8239 25.78 13278 55.41
missing 1408 15.29 836 16.49 3023 13.29 2745 14.53 4431 13.87 3581 14.94
Alcohol drinking status Never 4074 44.23 1765 34.81 3457 15.2 1399 7.4 7531 23.57 3164 13.2
Ever 5081 55.17 3256 64.22 19211 84.47 17362 91.89 24292 76.02 20618 86.04
missing 55 0.6 49 0.97 76 0.33 133 0.7 131 0.41 182 0.76
Alcohol (drinks / day) Never 4082 44.32 1767 34.85 3476 15.28 1404 7.43 7558 23.65 3171 13.23
0 to < 1 3293 35.75 1527 30.12 6899 30.33 2907 15.39 10192 31.9 4434 18.5
1 to < 3 1196 12.99 797 15.72 5772 25.38 3856 20.41 6968 21.81 4653 19.42
3 to < 5 200 2.17 323 6.37 2642 11.62 2716 14.37 2842 8.89 3039 12.68
5 to 109 1.18 427 8.42 3293 14.48 7119 37.68 3402 10.65 7546 31.49
missing 330 3.58 229 4.52 662 2.91 892 4.72 992 3.1 1121 4.68
Fruit consumption < 1 1368 14.85 1203 23.73 3974 17.47 4762 25.2 5342 16.72 5965 24.89
(pieces / week) 1 to 3 1454 15.79 741 14.62 3817 16.78 2803 14.84 5271 16.5 3544 14.79
3 to 7 1883 20.45 745 14.69 4158 18.28 2380 12.6 6041 18.91 3125 13.04
≥ 7 1806 19.61 620 12.23 3757 16.52 1887 9.99 5563 17.41 2507 10.46
missing 2699 29.31 1761 34.73 7038 30.94 7062 37.38 9737 30.47 8823 36.82
Vegetable consumption < 1 1382 15.01 997 19.66 3960 17.41 4180 22.12 5342 16.72 5177 21.6
(pieces / week) 1 to 3 1613 17.51 845 16.67 3924 17.25 3051 16.15 5537 17.33 3896 16.26
3 to 7 1757 19.08 802 15.82 3735 16.42 2474 13.09 5492 17.19 3276 13.67
≥ 7 1910 20.74 809 15.96 4216 18.54 2251 11.91 6126 19.17 3060 12.77
missing 2548 27.67 1617 31.89 6909 30.38 6938 36.72 9457 29.6 8555 35.7
Women Men Overall
Sex All
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Table 3   Adjusted Odds Ratios and 95%Confidence Intervals for the association between head and neck cancer overall and education level /
  monthly household income  
 
Controls Cases Controls Cases Controls Cases
OR LCI UCL
n studies, 
p het
OR LCI UCL
n studies, 
p het
OR LCI UCL
n studies, 
p het
Education
Level
Low 10301 9235 2.50 2.02 3.09 28, <.0001 10039 8748 1.87 1.53 2.29 27, <.0001 7680 7142 1.46 1.16 1.82 25, <.0001
Mid 10238 8370 1.80 1.57 2.07 30, <.0001 10046 8105 1.42 1.24 1.63 29, <.0001 6755 6331 1.32 1.15 1.53 26, <.0001
High 10925 5550 1.00 10778 5463 1.00 7184 3930 1.00
Monthly 
Income 
1 1568 1556 2.44 1.62 3.67 8, <0.0001 1544 1532 1.69 1.27 2.26 8, 0.016 733 1048 1.56 1.29 1.88 8, 0.53
2 828 590 1.60 1.11 2.32 8, 0.001 815 583 1.26 0.90 1.75 8, 0.0023 363 379 1.11 0.90 1.37 8, 0.54
3 853 521 1.31 0.93 1.84 9, 0.0009 846 520 1.14 0.80 1.62 9, 0.0018 436 383 1.10 0.80 1.53 9, 0.48
4 618 436 1.15 0.82 1.61 9, 0.0003 614 435 1.02 0.73 1.44 9, 0.0015 425 341 0.94 0.64 1.37 9, 0.0034
5 1976 1294 1967 1284 1516 1082
Controls Casesd Controls Casesd Controls Casesd
OR
Lower 
CI
Uppe
r CI
n studies, 
p het
OR
Lowe
r CI
Upper 
CI
n studies, 
p het
OR
Lower 
CI
Upper 
CI
n studies, 
p het
Education
Level
Low 5697 4932 1.43 1.13 1.81 19, <.0001 5013 4395 1.34 1.04 1.73 16, <.0001 1784 774 1.61 1.13 2.31 23, 0.1751
Mid 3690 3639 1.33 1.11 1.59 19, <.0001 3107 3240 1.22 1.03 1.46 16, <.0001 1476 372 1.10 0.90 1.34 26, 0.6039
High 4646 2342 1.00 4136 2149 1.00 1453 349 1.00
N - number of subjects; OR - Odds Ratio; CI - 95% Confidence Interval; n - number of studies; p het - p-value for heterogeneity; 
† Unconditional logistic regression (random-effects model); ref - reference category
1 Adjusted for: age, sex, center
2 Adjusted for: 1 + smoking status, smoking pack years (continuous), cigarettes per day, duration of smoking (years)    
3 Adjusted for: 2 + drinking status, alcohol frequency, years of drinking     
3x Adjusted for: 3 + interaction between years of smoking and years of drinking     
4 Adjusted for: 3 + fruit consumption, vegetable consumption 
5 Adjusted for: 4 + Tb - tobacco use: duration of pipe smoking, duration of cigar smoking, use of snuff, use of chewing tobacco  
6 Adjusted for: age, sex, center in never smokers, never tobacco users, and never alcohol drinkers
number number number
4. Adjusted for age, sex, center, 
smoking, alcohol and diet†   
2. Adjusted for age, 
sex, center, 
smoking†  
3. Adjusted for age, sex, center, 
smoking and alcohol†   
1. Minimally adjusted Adjusted 
for age, sex and  center†                         
number number number
6. Adjusted for age, sex, center, 
in never smokers/Tb/alcohol 
users†   
5. Adjusted for age, sex, center, 
smoking, alcohol, diet and Tb†   
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Table 4      Subgroup analyses – Random-effects unconditional logistic regression models: adjusted Odds Ratios and 95%Confidence Intervals in 
(1) minimally adjusted models and (2) models adjusted for significant behavioural factors for the association of low relative to high 
educational attainment in head and neck cancer subsites by: sex, age-group, over-time, source of control, cancer subsite, global 
region, and country income inequality. 
%unexplained by 
smoking and 
alcohol‡
Education low vs high OR Lower CI Upper CI n, p het* p het** OR Lower CI Upper CI n, p het* p het** %
Men 2.58 2.07 3.21 28, <.0001 0.097 1.44 1.16 1.80 25, <.0001 0.757 28.1
Women 1.89 1.41 2.54 24, <.0001 1.34 0.90 2.00 20, 0.008 38.0
< 50 years 2.19 1.68 2.85 25, 0.02 0.495 1.22 0.89 1.67 22, 0.033 0.123 18.3
50 + years 2.47 1.98 3.09 28, <.0001 1.65 1.32 2.05 27, <.0001 43.9
Pre-2000 studies 2.55 1.83 3.56 15, <.0001 0.924 1.27 0.88 1.82 13, <.0001 0.176 17.4
2000-onward studies 2.50 1.97 3.16 13, <.0001 1.70 1.37 2.11 12, 0.0099 46.7
Population controls 3.25 2.25 4.68 9, <.0001 0.058 1.62 1.17 2.23 7, 0.019 0.539 27.4
Hospital controls 2.16 1.75 2.66 19, <.0001 1.42 1.08 1.85 19, <.0001 36.0
Oral cavity 2.06 1.64 2.58 26, <.0001 0.043 1.33 1.02 1.75 25, <.0001 0.387 31.2
Oropharynx 2.34 1.66 3.31 24, 0.012 1.88 1.23 2.88 23, 0.085 65.7
Oral cavity /oropharynx NOS 2.21 1.76 2.78 26, <.0001 1.44 1.12 1.85 25, 0.0034 36.5
Hypopharynx 3.80 2.60 5.54 23, 0.00016 2.00 1.33 3.01 20, 0.024 35.8
Larynx 2.99 2.19 4.07 25, <.0001 1.69 1.24 2.32 22, <.0001 34.9
Europe 2.20 1.55 3.11 13, <.0001 0.047 1.30 0.88 1.93 10, <.0001 0.630 25.1
North America 3.00 2.05 4.39 13, <.0001 1.57 1.12 2.19 13, 0.0037 28.4
South/Central America 2.37 1.93 2.91 4, 0.37 1.68 1.31 2.16 4, 0.45 49.8
Lower income inequal country 2.22 1.33 3.73 6, <.0001 0.040 1.30 0.67 2.53 5, <.0001 0.002 24.4
Mid income inequal country 1.40 0.90 2.18 9, <.0001 1.17 0.77 1.78 7, 0.00018 42.3
Higher income inequal country 2.75 2.08 3.62 17, <.0001 1.65 1.27 2.15 17, <.0001 37.3
Minimally adjusted 
Adjusted for age, sex and  
center†                         
Adjusted for age, sex, center 
and smoking and alcohol†$   
 
comparison lowest to highest education level; † Unconditional logistic regression.; OR - Odds Ratio; CI - Confidence Interval; n - number of 
studies 
$ Adjusted for: smoking status, smoking pack years (continuous), cigarettes per day, smoking duration (years), drinking status, alcohol 
frequency, alcohol duration (years)      
p het * - p-value for heterogeneity within subgroups; p het ** - p-value for heterogeneity across subgroups;  
Difference in models expressed as a percentage computed to quantify amount of effect associated with low education explained by smoking and 
alcohol behaviours; ‡ proportion remaining after attributable fraction of covariates removed 100-(OR1-OR2/OR1-1)x100) 
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Figure 1 The risk of head and neck cancer associated with low relative to high education and low income relative to high income adjusted 
for smoking and alcohol behaviours, by study, and pooled.   
 
 
 
 
 
 
OR - Odds Ratios; 95%CI - 95% Confidence Intervals *USA Multicenter, Baltimore HOTSPOT, China (Beijing) no lowest group, second group (1v2 or 2v5)  
Squares - study specific odds ratios; Size of the squares - determined by the inverse of the variance of the log OR 
Horizontal lines - study specific 95% Confidence Intervals; Diamond - summary estimate combining the study specific estimates with random-effects models adjusted for age, sex, 
centre, smoking (smoking status, smoking pack years (continuous), cigarettes per day), and alcohol (alcohol drinking status, and alcohol frequency); Width of diamond – summary 
estimate 95% Confidence Interval Solid vertical line - odds ratio of 1; Dashed vertical line - summary odds ratio, “X studies removed refers to when studies leading to heterogeneity 
were removed. 
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Intervals in (1) minimally adjusted models and (2) models adjusted for smoking and alcohol – for 
the association of low relative to high educational attainment in global regions by: sex, and age- 
group. 
Supplementary Figure 1 - Galbraith plot of the studies included in the overall income analysis.  
(Studies contributing to Heterogeneity: Los Angeles) 
Supplementary Figure 2 - Galbraith plot of the studies included in the overall education analysis.  
(Studies contributing to Heterogeneity Germany – Heidelberg, Italy Multicenter, Switzerland, 
NY-1, NC-2, Tampa, France 2001-2007, Italy-Aviano).  
Supplementary Methods 
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Supplementary Table 1           Reference list of pooled studies 
 
INHANCE STUDY ID Original publication reference 
Aviano 
Negri E, La Vecchia C, Franceschi S, Tavani A. Attributable risk for oral cancer in northern Italy. Cancer 
Epidemiol Biomarkers Prev.1993;2:189-93. 
Baltimore 
D'souza G, Kreimer AR, Viscidi R et al. Case-control study of human papilloma virus and oropharyngeal 
cancer. N Engl J Med. 2007; 10;356: 1944-56. 
Beijing  
Zheng TZ, Boyle P, Hu HF et al. Dentition, oral hygiene, and risk of oral cancer: a case-control study in 
Beijing, People's Republic of China. Cancer causes control. 1990; 1: 235-41. 
Boston  
Peters ES, McClean MD, Liu M, et al. The ADH1C polymorphism modifies the risk of squamous cell 
carcinoma of the head and neck associated with alcohol and tobacco use. Cancer Epidemiol Biomarkers 
Prev.2005;14:476-82. 
Buffalo 
Jayaprakash V, Rigual NR, Moysich KB et al. Chemoprevention of Head and Neck Cancer With Aspirin. 
Arch Otolaryngol Head Neck Surg. 2006; 132:1231-6. 
Central Europe 
Hashibe M, Boffetta P, Zaridze D, Shangina O, Szeszenia-Dabrowska N, Mates D, Janout V, Fabiánová 
E, Bencko V, Moullan N, Chabrier A, Hung R, Hall J, Canzian F, Brennan P. Evidence for an important 
role of alcohol- and aldehyde-metabolizing genes in cancers of the upper aerodigestive tract. Cancer 
Epidemiol Biomarkers Prev. 2006;15:696-703. 
Germany-Heidelberg  
Dietz A, Ramroth H, Urban T, Ahrens W, Becher H. Exposure to cement dust, related occupational groups 
and laryngeal cancer risk: results of a population based case-control study. Int J Cancer.2004;108:907-11. 
Germany-Saarland  
Twardella D, Loew M, Rothenbacher D, Stegmaier C, Ziegler H, Brenner H. The diagnosis of a smoking-
related disease is a prominent trigger for smoking cessation in a retrospective cohort study. J Clin 
Epidemiol. 2006;59:82-9. 
HOTSPOT Publication in progress 
Houston 
Zhang Z, Shi Q, Liu Z, Sturgis EM, Spitz MR, Wei Q. Polymorphisms of methionine synthase and 
methionine synthase reductase and risk of squamous cell carcinoma of the head and neck: a case-control 
analysis. Cancer Epidemiol Biomarkers Prev.2005;14:1188-93. 
International Multicenter 
Herrero R, Castellsagué X, Pawlita M, Lissowska J, Kee F, Balaram P, Rajkumar T, Sridhar H, Rose B, 
Pintos J, Fernández L, Idris A, Sánchez MJ, Nieto A, Talamini R, Tavani A, Bosch FX, Reidel U, Snijders 
PJ, Meijer CJ, Viscidi R, Muñoz N, Franceschi S; IARC Multicenter Oral Cancer Study Group. Human 
papillomavirus and the risk of Human papillomavirus and oral cancer: the International Agency for 
Research on Cancer multicenter study. J Natl Cancer Inst.2003;95:1772-83. 
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Iowa 
Smith EM, Hoffman HT, Summersgill KS, Kirchner HL, Turek LP, Haugen TH. Human papillomavirus and 
risk of oral cancer. Laryngoscope.1998;108:1098Â¡V103. 
Italy Multicenter 
Bosetti C, Gallus, S, Trichopoulou A, Talamini R, Franceschi S, Negri E, et al. Influence of the 
Meditterranean diet on the risk of cancers of the upper aerodigestive tract. Cancer Epidemiol Biomarkers 
Prev.2003; 12: 1091-4. 
Latin America 
Szymańska K, Hung RJ, Wünsch-Filho V, Eluf-Neto J, Curado MP, Koifman S, Matos E, Menezes A, 
Fernandez L, Daudt AW, Boffetta P, Brennan P. Alcohol and tobacco, and the risk of cancers of the upper 
aerodigestive tract in Latin America: a case-control study. Cancer Causes Control.2011;22:1037-46. 
Los Angeles 
Cui Y, Morgenstern H, Greenland S, et al. Polymorphism of xeroderma pigmentosum group G and the risk 
of lung cancer and squamous cell carcinomas of the oropharynx, larynx and esophagus. Int J 
Cancer.2006;118:714-20. 
Milan (1984-1989) 
Franceschi S, Talamini R, Barra S, et al. Smoking and drinking in relation to cancers of the oral cavity, 
pharynx, larynx, and esophagus in northern Italy. Cancer Res.1990;50:6502-7 
Milan (2006-2009)  Publication in progress 
MSKCC 
Schantz SP, Zhang ZF, Spitz MS, Sun M, Hsu TC. Genetic susceptibility to head and neck cancer: 
interaction between nutrition and mutagen sensitivity. Laryngoscope.1997;107:765-81. 
North Carolina (1994-1997) 
Olshan AF, Weissler MC, Watson MA, Bell DA. GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 
polymorphisms, tobacco use, and the risk of head and neck cancer. Cancer Epidemiol Biomarkers 
Prev.2000;9:185-91. 
North Carolina (2002-2006) 
Divaris K, Olshan AF, Smith J, Bell ME, Weissler MC, Funkhouser WK, Bradshaw PT. Oral health and risk 
for head and neck squamous cell carcinoma: the Carolina Head and Neck Cancer Study. Cancer Causes 
Control. 2010; 4:567-75. 
NY Multicenter 
Muscat JE, Richie JP Jr., Thompson S, Wynder EL. Gender differences in smoking and risk for oral 
cancer. Cancer Res.1996;56:5192-97. 
Paris (2002-2005) 
Luce D, Stücker I; ICARE Study Group. Investigation of occupational and environmental causes of 
respiratory cancers (ICARE): a multicenter, population-based case-control study in France. BMC Public 
Health. 2011;11:928. 
Paris (1989-1991) 
Menvielle G, Luce D, Goldberg P, Leclerc A. Smoking, alcohol drinking, occupational exposures and 
social inequalities in hypopharyngeal and laryngeal cancer. Int J Epidemiol. 2004; 33 (4): 799-806. 
Puerto Rico 
Hayes RB, Bravo-Otero E, Kleinman DV, et al. Tobacco and alcohol use and oral cancer in Puerto Rico. 
Cancer Causes Control.1999;10:27-33. 
 28 
Sao Paulo 
Boing AF, Ferreira Antunes JL, de Carvalho MB, de Góis Filho JF, Kowalski LP, Michaluart P Jr; Head and 
Neck Genome Project/GENCAPO, Eluf-Neto J, Boffetta P, Wünsch-Filho V. How much do smoking and 
alcohol consumption explain socioeconomic inequalities in head and neck cancer risk? J Epidemiol 
Community Health. 2010; 65:709-14. 
Seattle (1985-1995) 
Rosenblatt KA, Daling JR, Chen C, Sherman KJ, Schwartz SM. Marijuana use and risk of oral squamous 
cell carcinoma. Cancer Res.2004;64:4049-54. 
Seattle-Leo  
Rogers MA, Thomas DB, Davis S, Vaughan TL, Nevissi AE. A case-control study of element levels and 
cancer of the upper aerodigestive tract. Cancer Epidemiol Biomarkers Prev. 1993 Jul-Aug;2(4):305-12. 
Switzerland 
Levi F, Pasche C, La Vecchia C, et al. Food groups and risk of oral and pharyngeal cancer. Int J Cancer 
1998;77:705-9. 
Tampa 
Elahi A, Zheng Z, Park J, Eyring K, McCaffrey T, Lazarus P. The human OGG1 DNA repair enzyme and 
its association with orolaryngeal cancer risk. Carcinogenesis.2002;23:1229-34. 
US Multicenter 
Blot WJ, McLaughlin JK, Winn DM, et al. Smoking and drinking in relation to oral and pharyngeal cancer. 
Cancer Res.1988; 48:3282. 
Western Europe 
Lagiou P, Georgila C, Minaki P, Ahrens W, Pohlabeln H, Benhamou S, Bouchardy C, Slamova A, 
Schejbalova M, Merletti F, Richiardi L, Kjaerheim K, Agudo A, Castellsague X, Macfarlane TV, Macfarlane 
GJ, Talamini R, Barzan L, Canova C, Simonato L, Lowry R, Conway DI, McKinney PA, Znaor A, McCartan 
BE, Healy C, Nelis M, Metspalu A, Marron M, Hashibe M, Brennan PJ. Alcohol-related cancers and 
genetic susceptibility in Europe: the ARCAGE project: study samples and data collection. Eur J Cancer 
Prev.2009;18:76-84. 
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Supplementary Table 2           Household income categorisation 
 
 
Study 
1 2 3 4 5
Iowa < $20,000 - $20,000- $39,999 $40,000- $59,999 ≥$60,000 
Los Angeles < $10,000 or $10,000-
$19,999
$20,000- $29,999 $30,000-$39,999 $40,000- $59,999 $60,000- $79,999 or 
80,000- $99,999 or 
≥$100,000 
Houston (MD Anderson) < $15,000 $15,000-$19,000 or 
$20,000- $24,999  
$25,000- $34,999 $35,000- $49,999 $50,000- $74,999 or 
75,000- $99,999 or 
over $100,000 
Puerto Rico < $15,000 more than $20,000 more than $25,000 or 
more than $30,000 or 
more than $35,000 
more than $40,000 
or more than 
$45,000
more than $50,000 
Boston (Harvard) $9,000 or $9,000-
$14,999 
$15,000-$19,999 or 
$20,000-$24,999 or 
$25,000-$29,999
$30,000-$39,999 $40,000-$49,999 $50,000-$79,999 or 
80,000-$99,999 or 
100,000
MSKCC under $13,000 $13,000- $22,999 or 
23,000 - $32,999 
$33,000 - $42,999 $43,000 - $52,999 $53,000-$62,999 or 
over $63,000
Buffalo <16,000 16000-29,999 ≥ 30,000 - -
UNC - pop-based < $5,000 or $5,001-
$10,000 or $10,001-
$20,000 
$20,001-$30,000 $30,000-$40,000 $40,001-$50,000 $50,001-$60,000 or 
$60,001-$70,000 or 
$70,001- $80,000 or 
≥$80,001  
Baltimore < $ 20, 000 $ 20,001- $30,000 $30,001-$40,000 $40,001-$50,000 ≥ $ 50,001 
HOTSPOT - <30,000 30,000-49,999 50,000-100,000 >100,000 
Codes
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Supplementary Table 3       Distribution of selected behavioural factors by educational attainment in the study population 
Lower Mid Higher
n % n % n %
Cigarette smoking status Never 5488 28.09 4601 24.72 5683 34.49 <.0001
Former 6042 30.93 5471 29.4 5428 32.94
Current 7470 38.24 8179 43.95 5237 31.78
missing 536 2.74 358 1.92 129 0.78
Cigarette pack-years mean 28.1 29.8 22.4 <.0001
Cigarette smoking 0 5490 28.1 4601 24.72 5683 34.49
(pack years) 0 <=10 1642 8.4 1828 9.82 2243 13.61
10-<=20 1919 9.82 1844 9.91 1649 10.01
20-<=30 2123 10.87 2043 10.98 1501 9.11
30-<=40 2175 11.13 2165 11.63 1492 9.06
40-<=50 1814 9.29 1723 9.26 1149 6.97
> 50 3641 18.64 3950 21.23 2534 15.38
missing 732 3.75 455 2.45 226 1.37
Alcohol drinking status Never 4130 21.14 3427 18.42 2901 17.61 <.0001
Ever 15312 78.38 15103 81.16 13538 82.16
missing 94 0.48 79 0.42 38 0.23
Years of drinking mean 33.76 32.78 32.78 <.0001
Alcohol (drinks / day) Never 4153 21.26 3431 18.44 2908 17.65 <.0001
0 to < 1 2627 13.45 5163 27.74 6620 40.18
1 to < 3 3689 18.88 4076 21.9 3611 21.92
3 to < 5 2384 12.2 2028 10.9 1338 8.12
5 to 5844 29.91 3274 17.59 1531 9.29
missing 839 4.29 637 3.42 469 2.85
Fruit consumption < 1 4317 22.1 3550 19.08 3218 19.53 <.0001
(pieces / week) 1 to 3 3470 17.76 2548 13.69 2645 16.05
3 to 7 3473 17.78 2654 14.26 2887 17.52
≥ 7 2807 14.37 2688 14.44 2448 14.86
missing 5469 27.99 7169 38.52 5279 32.04
Vegetable consumption < 1 4372 22.38 3197 17.18 2734 16.59 <.0001
(pieces / week) 1 to 3 3662 18.74 2873 15.44 2712 16.46
3 to 7 3241 16.59 2568 13.8 2816 17.09
≥ 7 3154 16.14 2892 15.54 3028 18.38
missing 5107 26.14 7079 38.04 5187 31.48
Region Europe 10946 56.03 9146 49.15 5602 34 <.0001
North America 1117 5.72 7296 39.21 10225 62.06
South/Central America 6018 30.8 1530 8.22 575 3.49
Other 1455 7.45 637 3.42 75 0.46
p for chi-sq / 
anova
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Supplementary Table 4      Adjusted Odds Ratios and 95%Confidence Intervals for the association between head and neck cancer overall and 
                                             education level monthly household income using complete observation only dataset 
 
 
Controls Cases
OR LCI UCI
n studies, 
p het
OR LCI UCI
n studies, 
p het
OR LCI UCI
n studies, 
p het
OR LCI UCI
n 
studies, 
p het
OR LCI UCI
n studies, 
p het
Education
Level
Low 5013 4395 2.12 1.59 2.84 16, <.0001 1.61 1.27 2.03 16, <.0001 1.37 1.04 1.80 16, <.0001 1.35 1.05 1.73 16, <.0001 1.34 1.04 1.73 16, <.0001
Mid 3107 3240 1.69 1.35 2.11 16, 0.0001 1.39 1.16 1.66 16, <.0001 1.25 1.05 1.50 16, <.0001 1.23 1.03 1.47 16, <.0001 1.22 1.03 1.46 16, <.0001
High 4136 2149 1.00 1.00 1.00 1.00 1.00
Monthly 
Income 
1 733 1048 2.77 1.24 6.21 4, <.0001 1.93 1.10 3.38 4, 007 1.54 1.09 2.16 4, 0.20 1.60 1.20 2.12 4, 0.31 1.62 1.19 2.19 4, 0.28
2 363 379 1.63 1.14 2.32 4, 0.16 1.18 0.92 1.51 4, 0.68 1.03 0.80 1.33 4, 0.65 1.05 0.81 1.37 4, 0.59 1.06 0.82 1.39 4, 0.58
3 436 383 1.48 1.17 1.87 4, 0.52 1.16 0.90 1.51 4, 0.97 1.06 0.81 1.38 4, 0.98 1.09 0.83 1.43 4, 0.98 1.09 0.84 1.43 4, 0.98
4 425 341 1.47 1.17 1.85 4, 0.67 1.23 0.96 1.58 4, 0.83 1.17 0.91 1.51 4, 0.59 1.19 0.92 1.54 4,0.56 1.19 0.92 1.55 4, 0.59
5 1516 1082 1.00 1.00 1.00 1.00 1.00
* fixed-effects model p-value for heterogeneity (p het) > 0.05
1 Adjusted for: age, sex, center
2 Adjusted for: 1 + smoking status, smoking pack years (continuous), cigarettes per day, duration of smoking (years)    
3 Adjusted for: 2 + drinking status, alcohol frequency, years of drinking     
3x Adjusted for: 3 + interaction between years of smoking and years of drinking     
4 Adjusted for: 3 + fruit consumption, vegetable consumption 
5 Adjusted for: 4 + Tb - tobacco use: duration of pipe smoking, duration of cigar smoking, use of snuff, use of chewing tobacco  
N - number of subjects; OR - Odds Ratio; CI - 95% Confidence Interval; n - number of studies; p het - p-value for heterogeneity; † Unconditional logistic regression (random-effects model); ref - 
reference category
4. Adjusted for age, sex, 
center, smoking, alcohol and 
diet†   
5. Adjusted for age, sex, 
center, smoking, alcohol, diet 
and Tb†   
1. Minimally adjusted 
Adjusted for age, sex and  
center†                         
2. Adjusted for age, 
sex, center, smoking†  
3. Adjusted for age, sex, center, 
smoking and alcohol†   
n
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Supplementary Table 5    Subgroup analyses - Adjusted Odds Ratios and 95%Confidence Intervals in (1) minimally adjusted models and (2)       
                                            models adjusted for smoking and alcohol - for the association of low relative to high educational attainment in head and 
                                            neck cancer subsites for global regions by: sex, and age-group 
 
Education low vs high                             
(cases / controls)
Oral 
cavity
het het het het het
OR LCI UCI n, p-het* OR LCI UCI n, p-het* OR LCI UCI n, p-het* OR LCI UCI n, p-het* OR LCI UCI n, p-het*
All (n / n ) 2.06 1.64 2.58 26, <.0001 2.34 1.66 3.31 24, 0.012 2.21 1.76 2.78 26, <.0001 3.80 2.60 5.54 23, 0.00016 2.99 2.19 4.07 25, <.0001
Region          Europe (n / n) 1.50 1.03 2.19 11, <.0001 0.123 2.05 1.40 2.99 11, <.0001 0.703 2.56 1.46 4.50 10, 0.032 0.897 4.04 2.38 6.85 10, 0.0004 0.821 2.17 1.41 3.33 12, <.0001 0.008
                       North America 2.59 1.75 3.82 13, 0.0008 2.38 1.59 3.56 13, 0.00032 2.17 1.42 3.31 11, 0.26 3.49 1.65 7.37 11, 0.007 4.73 2.77 8.09 11, <.0001
                       South/Central America 2.18 1.63 2.92 4, 0.50 2.64 1.64 4.23 4, 0.23 2.45 0.51 11.91 3, 0.049 3.54 1.83 6.84 2, 0.488 2.60 1.05 6.43 2, 0.011
Sex                 Men 2.21 1.77 2.77 26, 0.0004 0.089 2.43 1.89 3.13 26, <.0001 0.002 2.44 1.67 3.56 24, 0.079 0.903 4.28 2.80 6.53 21, <.0001 0.008 2.87 2.10 3.92 25, <.0001 0.813
                        Women 1.57 1.14 2.18 23, 0.012 1.33 1.00 1.77 21, 0.93 2.53 1.63 3.93 18, 0.61 1.52 0.81 2.87 18, 0.97 3.07 1.94 4.88 20, 0.0090
Age-group    Young < 50 years 1.64 1.10 2.43 22, 0.085 0.274 2.59 1.86 3.61 21, 0.57 0.475 2.57 1.58 4.20 18, 0.99 0.999 2.48 1.35 4.57 16, 0.99 0.209 2.99 2.06 4.33 21, 0.33 0.792
                     Older 50 + years 2.11 1.70 2.62 26, 0.0002 2.23 1.75 2.84 26, <.0001 2.23 1.54 3.22 23, 0.052 3.96 2.65 5.91 23, 0.00071 2.80 2.04 3.84 25, <.0001
All 1.33 1.02 1.75 25, <.0001 1.88 1.23 2.88 23, 0.085 1.44 1.12 1.85 25, 0.0034 2.00 1.33 3.01 20, 0.024 1.69 1.24 2.32 22, <.0001
Region          Europe 1.10 0.69 1.75 10, <.0001 0.259 1.51 0.99 2.30 10, 0.0053 0.734 2.62 1.69 4.06 9, 0.82 0.427 2.23 1.28 3.88 8, 0.055 0.394 1.29 0.79 2.10 9, <.0001 0.292
                       North America 1.34 0.91 1.98 13, 0.15 1.30 0.91 1.85 13, 0.16 1.70 1.00 2.88 11, 0.422 1.69 0.72 4.00 10, 0.042 2.24 1.36 3.70 11, 0.011
                       South Central America 1.77 1.24 2.53 4, 0.042 1.70 0.89 3.23 4, .018 1.40 0.18 11.22 3, 0.011 1.91 0.87 4.22 2, 0.529 1.94 0.74 5.09 2, 0.021
Sex                 Men 1.33 1.03 1.72 25, 0.0098 0.740 1.57 1.21 2.04 24, 0.0073 0.079 1.67 1.16 2.40 22, 0.41 0.137 2.14 1.33 3.46 18, 0.010 0.313 1.57 1.15 2.14 22, <.0001 0.920
                        Women 1.18 0.61 2.28 19, 0.0014 0.98 0.64 1.50 17, 0.91 3.41 1.43 8.13 17, 0.82 1.15 0.38 3.48 12, 1.00 1.52 0.88 2.64 11, 0.41
Age-group    Young < 50 years 0.73 0.46 1.17 15, .025 0.012 0.73 0.46 1.17 15, 0.25 0.007 1.23 0.54 2.84 14, 0.99 0.434 0.80 0.27 2.37 13, 1.00 0.101 1.82 0.87 3.80 13, 0.037 0.719
                     Older 50 + years 1.43 1.13 1.80 25, 0.053 1.43 1.13 1.80 25, 0.054 1.81 1.10 2.97 20, 0.096 2.14 1.36 3.35 19, 0.41 1.57 1.14 2.18 22, <.0001
(ii) Adjusted for age, sex, center and smoking and alcohol  OR (95% CI)
(i) Adjusted for age, sex and center†  OR (95% CI)
OC/OP 
NOS
Oropharynx Hypopharynx Larynx 
 
† - unconditional logistic regression (random-effects model) 
OR - Odds Ratio; UCI - Upper 95% Confidence Interval; LCI - Lower 95% Confidence Interval; n = number of studies 
p het * - p-value for heterogeneity within subgroups; p het ** - p-value for heterogeneity across subgroups 
1. Adjusted for: age, sex, centre 
2. Adjusted for: 1. + smoking status, smoking pack years (continuous), cigarettes per day, smoking duration (years), drinking status, alcohol 
frequency, alcohol duration (years) 
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Supplementary Table 6      Subgroup analyses - Adjusted Odds Ratios and 95%Confidence Intervals in (1) minimally adjusted models and (2)  
                                              models adjusted for smoking and alcohol - for the association of low relative to high educational attainment in global 
                                              regions by: sex, and age-group 
Education low vs high                               
(n cases / controls)
OR LCI UCI n, p-het* p-het** OR LCI UCI n, p-het* p-het** OR LCI UCI n, p-het* p-het**
All (n / n ) 2.20 1.55 3.11 13, <.0001 3.00 2.05 4.39 13, <.0001 2.37 1.93 2.91 4, 0.37
Sex                 Men (n / n ) 2.34 1.64 3.34 13, <.0001 0.044 3.00 2.04 4.40 13, <.0001 0.508 2.41 1.93 3.01 4, 0.42 0.585
                        Women 1.32 0.86 2.03 10, 0.00042 2.44 1.52 3.94 12, 0.0065 2.10 1.35 3.26 4, 0.42
Age-group      Young < 50 years 2.24 1.40 3.58 12, <.0001 0.816 1.94 1.24 3.05 11, 1.00 0.142 1.93 1.25 2.99 4, 0.91 0.318
                        Older 50 + years 2.09 1.48 2.97 13, <.0001 3.06 2.03 4.60 13, <.0001 2.48 1.97 3.11 4, 0.42
All 1.30 0.88 1.93 10, <.0001 1.57 1.12 2.19 13, 0.0037 1.68 1.31 2.16 4, 0.45
Sex                 Men 1.35 0.92 1.99 10, <.0001 0.385 1.45 1.07 1.97 13, 0.048 0.795 1.60 1.19 2.16 4, 0.35 0.455
                        Women 0.97 0.51 1.83 8, 0.0046 1.60 0.81 3.14 10, 0.22 2.40 0.86 6.64 3, 0.22
Age-group      Young < 50 years 1.04 0.65 1.66 10, 0.034 0.431 1.03 0.52 2.03 7, 0.81 0.241 1.27 0.73 2.22 3, 0.59 0.337
                        Older 50 + years 1.33 0.90 1.98 10, <.0001 1.64 1.12 2.38 13, 0.0017 1.74 1.26 2.40 4, 0.32
(i) Adjusted for age, sex and center†  OR (95% CI)
(ii) Adjusted for age, sex, center and smoking and alcohol†$ OR (95% CI)
Europe
South/Central America
North America
 
† - unconditional logistic regression (random-effects model) 
OR - Odds Ratio; UCI - Upper 95% Confidence Interval; LCI - Lower 95% Confidence Interval; n = number of studies 
p het * - p-value for heterogeneity within subgroups; p het ** - p-value for heterogeneity across subgroups 
1. Adjusted for: age, sex, centre 
2. Adjusted for: 1. + smoking status, smoking pack years (continuous), cigarettes per day, smoking duration (years), drinking status, alcohol 
frequency, alcohol duration (years) 
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Supplementary Figure 1        Galbraith plot of the studies included in the overall income analysis. (Studies contributing to 
                                                 Heterogeneity: Los Angeles) 
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Supplementary Figure 2         Galbraith plot of the studies included in the overall education analysis. (Studies contributing to Heterogeneity  
                                                  Germany- Heidelberg, Italy Multicenter, Switzerland, NY-1, NC-2, Tampa, France-2 2001-2007, Italy-Avino)  
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Supplementary Figure 3          Funnel plot of estimates around the summary estimate (vertical line) of the effect of low vs high educational  
                                                   attainment         
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Supplementary Methods 
 
ICD Codes : The case subjects had histologically confirmed diagnoses of cancers of the oral cavity (ICD-10 C00.3-C00.9, C02.0-C02.3, C03.0, 
C03.1, C03.9, C04.0, C04.1, C04.8, C04.9, C05.0, C06.0-C06.2, C06.8, and C06.9; 2); oropharynx (C01.9, C02.4, C05.1, C05.2, C09.0, C09.1, 
C09.8, C09.9, C10.0-C10.4, C10.8, C10.9; 3); hypopharynx (C12.9, C13.0-C13.2, C13.8, and C13.9; 4); oral cavity, oropharynx not otherwise 
specified (C02.8, C02.9, C05.8, C05.9, C14.0, C14.2, C14.8; 5) larynx (C32.0-C32.3, C32.8-C32.9). 
 
Modelling approach We started with a minimally adjusted model including age, sex and centre/location (for multi-centered studies) and 
increased model complexity to evaluate the relative contribution of risk factors to the association between education and income and head and 
neck cancer. Our “full model” used in all subgroup analyses consisted of adjusting for age, sex, cigarette smoking status, cigarettes per day 
while smoking, duration of smoking (years) and cumulative cigarette smoking (in pack-years)[-collectively smoking variables henceforth labelled 
“smoking”], alcohol consumption status, drinks per day while drinking and duration of alcohol (years)1 [-alcohol”]. We included variables for fruit 
and vegetable consumption (based on centre-specific quartiles)2 [-“diet”]; and other tobacco use (snuff, chewing tobacco, pipes, and cigars) 
status and duration of use where studies collected this information [-“other tobacco”], although we did not include Asian tobacco-related 
behaviours such as betel chewing in this analysis.  
 
Subgroup analyses We conducted subgroup analysis by smoking status; drinking status; cancer subsite; geographic region (Europe, North 
America, South/Central America, and Other regions including Africa, Asia, and Australia – results for the Other regions grouping due to limited 
sample size); age-group (<50 years vs. ≥50 years); and country income inequality (using ratios of income share of richest 20% of the country’s 
population to income share of poorest 20% grouped into tertiles– low income inequality <6; mid income inequality 6-8; higher income inequality 
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>8).3,4 We also conducted sensitivity analyses by control type (population-based vs. hospital-based) and year that the study was conducted 
(before vs. after 2000). 
 
Meta-analytic techniques and evaluation of heterogeneity Heterogeneity was evaluated for each of the summary estimates based on a test 
of the Cochrane Q statistic. Where there was evidence of heterogeneity across studies, we evaluated the source of heterogeneity by meta-
regression using control type, prevalence of ever smoking among controls, median year of the study period and global region as predictors in 
the model. If the heterogeneity could not be accounted for by the different study characteristics, an influence analysis was conducted to 
evaluate the source of heterogeneity from single studies by examining Galbraith plots and the contribution of each study to the Q-
statistic.Comparisons within studies in which one or more of the exposure categories had no subjects were excluded from that comparison 
group in the pooled analysis as the OR could not be estimated. This lead to different numbers of studies across the pooled comparison groups. 
 
Supplementary Methods References 
1. Hashibe M, Brennan P, Benhamou S, et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk 
of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst 
2007; 99: 777-89. 
2. Chuang SC, Jenab M, Heck JE, et al. Diet and the risk of head and neck cancer: a pooled analysis in the INHANCE consortium. Cancer 
Causes Control. 2012; 23: 69-88. 
3. Pickett KE, Shona K, Brunner E, Lobstein T, Wilkinson RG. Wider income gaps, wider waistbands? An ecological study of obesity and 
income inequality. J Epidemiol Community Health 2005; 59: 670-674. 
4. United Nations Development Program. Human development report. New York: Oxford University Press, 2003. 
